2019 ´ëÇѽÉÀåÇÐȸ Ç÷°ü¿¬±¸È¸ µ¿°è½ÉÆ÷Áö¾ö : 2019-12-14±³À°ÀÏÀÚ : 2019-12-14
±³À°Àå¼Ò : ±×·£µå ¿öÄ¿Èú ¼¿ï 3Ãþ ÄÚ½º¸ð½ºÈ¦
±³À°ÁÖÁ¦ :
2019 ´ëÇѽÉÀåÇÐȸ Ç÷°ü¿¬±¸È¸ µ¿°è½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Ç÷°ü¿¬±¸È¸
´ã´çÀÚ : ÀÌÀ¯¸®
¿¬¶ôó : 02-701-7023
À̸ÞÀÏ :
kvrwg@circulation.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í 1. »çÀüµî·Ï: ±³¼ö ¹× °³¿øÀÇ 30,000¿ø, Àü°øÀÇ ¹× ±âŸ: 20,000¿ø / 2. ÇöÀåµî·Ï: ±³¼ö ¹× °³¿øÀÇ 50,000¿ø, Àü°øÀÇ ¹× ±âŸ: 30,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12-14 ÄÚ½º¸ð½ºÈ¦ 09:10~09:30 Need for noninvasive continuous BP monitoring Æí¿í¹ü(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 12-14 ÄÚ½º¸ð½ºÈ¦ 09:30~09:50 Patch sensor typed BP measurement ±èÈñÂù(¼¿ïÀÇ´ë)
±³À°½Ã°£ 12-14 ÄÚ½º¸ð½ºÈ¦ 09:50~10:10 Skin-attachable BP measurement Àå°æÀÎ(DGIST)
±³À°½Ã°£ 12-14 ÄÚ½º¸ð½ºÈ¦ 10:10~10:30 Real-world analysis of continuous BP monitoring data ÀÌÇØ¿µ(¼¿ïÀÇ´ë)
Åä·Ð 12-14 ÄÚ½º¸ð½ºÈ¦ 10:30~10:40 Panel Discussion ¹ÚÁöÈ£ ±èâ¼ö ±è¼ºÈ¯(KAIST ¿Ü)
ÈÞ½Ä 12-14 ÄÚ½º¸ð½ºÈ¦ 10:40~11:00 Coffee Break ()
±³À°½Ã°£ 12-14 ÄÚ½º¸ð½ºÈ¦ 11:00~11:15 °ËÁø Ç÷°ü ³ªÀÌÀÇ ÀÇ¹Ì¿Í ÇÔÁ¤ ÀÓ»óÇö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 12-14 ÄÚ½º¸ð½ºÈ¦ 11:15~11:30 °íÇ÷¾Ð ´ç´¢ ȯÀÚ¿¡ ÇÊ¿äÇÑ Ç÷°ü°Ë»ç ½ÅÁøÈ£(ÇѾçÀÇ´ë)
±³À°½Ã°£ 12-14 ÄÚ½º¸ð½ºÈ¦ 11:30~11:45 Ç÷°ü°Ë»ç °á°ú¿¡ µû¸¥ ¾à¹° Ä¡·á ÇÊ¿äÇÑ°¡? Á¶ÀºÁÖ(°¡Å縯ÀÇ´ë)
Åä·Ð 12-14 ÄÚ½º¸ð½ºÈ¦ 11:45~12:00 Panel Discussion À̼±±â ±èÁÖÇÑ °¿õö(ÇѸ²ÀÇ´ë ¿Ü)
±³À°½Ã°£ 12-14 ÄÚ½º¸ð½ºÈ¦ 12:00~13:00 Can we modulate vascular aging by RAS inhibition? ¹Ú¼ºÇÏ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 12-14 ÄÚ½º¸ð½ºÈ¦ 13:00~13:15 Arterial Stiffness °½ÃÇõ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 12-14 ÄÚ½º¸ð½ºÈ¦ 13:15~13:30 Endothelial Function Test ÀÌÂùÁÖ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 12-14 ÄÚ½º¸ð½ºÈ¦ 13:30~13:45 Carotid Duplex Ultrasound Á¤Çý¹®(°æÈñÀÇ´ë)
±³À°½Ã°£ 12-14 ÄÚ½º¸ð½ºÈ¦ 13:45~14:00 Ultrasound for Abdominal Aortic Aneurysm ¹ÚÁø¼±(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 12-14 ÄÚ½º¸ð½ºÈ¦ 14:00~14:15 Ultrasound for Renal Artery ±è¼º¾Ö(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 12-14 ÄÚ½º¸ð½ºÈ¦ 14:15~14:30 Ultrasound for Deep Vein Thrombosis ½ÉÁö¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 12-14 ÄÚ½º¸ð½ºÈ¦ 14:30~15:10 Hands-on ÀÌÂùÁÖ Á¤Çý¹® ¼ÕÁ¤¿ì ½ÉÁö¿µ ÃÖÀÚ¿¬(¿¬¼¼ÀÇ´ë ¿Ü)
±³À°½Ã°£ 12-14 ÄÚ½º¸ð½ºÈ¦ 15:10~15:30 Vascular calcification in chronic kidney disease patients ÀÌ¿µ±â(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 12-14 ÄÚ½º¸ð½ºÈ¦ 15:30~15:50 Cardiovascular prevention in patients with chronic kidney disease Á¤ÇýÀ±(ºÐ´çÂ÷º´¿ø)
±³À°½Ã°£ 12-14 ÄÚ½º¸ð½ºÈ¦ 15:50~16:10 Cardiovascular safety of urate lowering therapies ¹ÚÁø±Õ(¼¿ïÀÇ´ë)
Åä·Ð 12-14 ÄÚ½º¸ð½ºÈ¦ 16:10~16:20 Panel Discussion ¿ÀÁØÇõ ·ùµ¿¿ ¼ÕÀå¿ø ÀÌÈñ¼±(ºÎ»êÀÇ´ë ¿Ü)